Printer Friendly

Pharmacopeia Subsidiary Buys Software Company.

Princeton, NJ and Cambridge, England 6/21/01--Accelrys, Pharmacopeia's software subsidiary (see IBO 4/15/01), has acquired Synomics Ltd. for $4 million. Synomics develops integrated software technology for life science research, emphasizing customization, shared access and enterprise-wide systems. Accelrys stated that the acquisition will give it access to technology for integrated software solutions, consulting expertise and a highly qualified staff. The acquisition will slightly dilute 2001 earnings.

* Synomics gives Accelrys more bioinformatics talent and complements the integrated approach that is the next stage of bioinformatics as companies seek to standardize and create unified data analysis systems. The acquisition also benefits Accelrys' consulting business as consulting becomes a key competitive market for bioinformatics companies.
COPYRIGHT 2001 Strategic Directions International Inc. (SDI)
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2001 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:Accelrys acquires Synomics Ltd.
Comment:Pharmacopeia Subsidiary Buys Software Company.(Accelrys acquires Synomics Ltd.)
Publication:Instrument Business Outlook
Article Type:Brief Article
Geographic Code:4EUUK
Date:Jun 30, 2001
Words:114
Previous Article:Waters Cuts Second Quarter Growth Forecast.
Next Article:Agilent Transfers Product to Gerstel.
Topics:


Related Articles
Oxford Molecular Sells Businesses.
Executive Briefing.
WISCONSIN PACKAGE PROVIDES ACCESS TO SEQSTORE DATABASES.
Eos transfers lead antibody target to Pharmacopeia.
ACCELRYS TO PROVIDE 10,000 PROTEIN SEQUENCES.
INCYTE GENOMICS SIGNS AGREEMENT WITH ACCELRYS.
Pharmacopeia achieves success in collaboration with Berlex.
Pharmacopeia and Kowa form inflammation research collaboration.
Pharmacopeia achieves milestone in collaboration with Berlex.
Pharmacopeia achieves milestone in collaboration with Berlex.

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters |